<p><p>Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson </p><p>Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle</p><p>Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey a
Fragment-Based Drug Discovery and X-Ray Crystallography
โ Scribed by Daniel A. Erlanson (auth.), Thomas G. Davies, Marko Hyvรถnen (eds.)
- Publisher
- Springer-Verlag Berlin Heidelberg
- Year
- 2012
- Tongue
- English
- Leaves
- 234
- Series
- Topics in Current Chemistry 317
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson
Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle
Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey and Roderick E. Hubbard
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors, by Daniel F. Wyss, Yu-Sen Wang, Hugh L. Eaton, Corey Strickland, Johannes H. Voigt, Zhaoning Zhu and Andrew W. Stamford
Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery, by Michael Hennig, Armin Ruf and Walter Huber
Targeting ProteinโProtein Interactions and Fragment-Based Drug Discovery, by Eugene Valkov, Tim Sharpe, May Marsh, Sandra Greive and Marko Hyvรถnen
Fragment Screening and HIV Therapeutics, by Joseph D. Bauman, Disha Patel and Eddy Arnold
Fragment-Based Approaches and Computer-Aided Drug Discovery, by Didier Rognan
โฆ Table of Contents
Front Matter....Pages i-xi
Introduction to Fragment-Based Drug Discovery....Pages 1-32
Fragment Screening Using X-Ray Crystallography....Pages 33-59
Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening....Pages 61-82
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors....Pages 83-114
Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery....Pages 115-143
Targeting ProteinโProtein Interactions and Fragment-Based Drug Discovery....Pages 145-179
Fragment Screening and HIV Therapeutics....Pages 181-200
Fragment-Based Approaches and Computer-Aided Drug Discovery....Pages 201-222
Back Matter....Pages 223-225
โฆ Subjects
Organic Chemistry; Crystallography; Pharmaceutical Sciences/Technology
๐ SIMILAR VOLUMES
<p><p>Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson </p><p>Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle</p><p>Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey a
<P>Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is
<P>Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is
<p>From its origins as a niche technique more than 15 years ago, fragment-based approaches have become a major tool for drug and ligand discovery, often yielding results where other methods have failed. Written by the pioneers in the field, this book provides a comprehensive overview of current meth